GeVIR Banner

Export Results to CSV Clear Search

Genes Fold Enrichment Color Codes
  • Gene Name, Canonical Transcript - gene identifiers from gnomAD database (Build 37)
  • GeVIR % - gene rank measured in percentiles based on Gene Variation Intolerance Ranking (GeVIR) (low values indicate more variation intolerant genes, which is also true for "LOEUF %" and "VIRLoF %"). GeVIR is a method which we developed and applied on a list of 19,361 genes to sort them based on number, length and evolutionary conservation of regions without functional variants (i.e. between two missense, loss-of-function, insertion or delition variants) in gnomAD database (version 2.0.1). Only canonical transcripts were analysed.
  • LOEUF % - gene rank measured in percentiles based gnomAD loss-of-function observed/expected upper bound fraction (LOEUF) (see Figure 1). For more information about this metric, please read "Constraint" section of MacArthur Lab blog post. If you use this metric please cite gnomAD flagship paper and use most up-to-date values from gnomAD website.

    LoF observed/expected (o/e) upper Confidence Interval (CI)

    Figure 1. Screenshot of ELN gene constraint metrics from gnomAD browser

  • VIRLoF % - gene rank measured in percentiles based on both GeVIR and gnomAD LOEUF (shows the best overall performance, see Figure 2). If you use this metric please cite both GeVIR and gnomAD flagship paper.
  • GeVIR AD, LOEUF AD, VIRLoF AD, GeVIR AR, LOEUF AR, VIRLoF AR - to help users interpret gene ranks, we calculated fold enrichment of Autosomal Dominant (AD) and Autosomal Recessive (AR) genes with known molecular basis of disorder in OMIM in a range of +-5% of gene X (see Figure 2). Statistical significant fold enrichements (Fisher Exact Test p-value < 1e-5) are shown in bold in the table. For example CDK19 gene's GeVIR % is 2.37, so examined range is from 0 (2.37-5, rounded to minimal percentile) to 7.37% (2.37+5). Genes in this range are ~4 times more often (4.05 fold enrichement) associated with AD diseases and ~4 times less often (0.25 fold enrichement) associated with AR diseases. Both enrichment of AD genes and deficiency of AR genes is statistical significant. Thus GeVIR metric adds supportive evidence that CDK19 is more likely to be associated with AD than AR disease.

    Gene Percentiles AD AR Fold Enrichment

    Figure 2. Fold Enrichment of known Autosomal Dominant (AD) and Autosomal Recessive (AR) genes of each gene in the ranked lists (GeVIR, LOEUF, VIRLoF. AD genes are enriched among top ranked genes (lowest percentiles), whereas AR genes are enriched among middle ranked genes (approximetly 35-65 percentiles). Combined metric (VIRLoF, purple) shows the best perfornance, i.e. high ranked genes are more often associated with AD than AR diseases, low ranked genes are less often associated with both AD and AR diseases.
Gene Name Canonical Transcript GeVIR % LOEUF % VIRLoF % GeVIR AD LOEUF AD VIRLoF AD GeVIR AR LOEUF AR VIRLoF AR
CCDC140 ENST00000295226 98.00 98.89 99.69 0.11 0.17 0.12 0.11 0.14 0.04
RP11-429E11.3 ENST00000317652 99.48 97.57 99.70 0.11 0.22 0.12 0.13 0.20 0.04
TAS2R14 ENST00000537503 99.19 97.83 99.70 0.11 0.21 0.12 0.12 0.17 0.04
AC020922.1 ENST00000539076 99.04 97.99 99.71 0.11 0.20 0.12 0.12 0.17 0.04
AL357673.1 ENST00000536061 99.36 97.74 99.71 0.11 0.21 0.12 0.12 0.17 0.04
CXorf67 ENST00000342995 99.08 99.57 99.72 0.11 0.16 0.12 0.12 0.12 0.04
PRNT ENST00000326539 97.32 97.61 99.72 0.10 0.22 0.12 0.11 0.20 0.04
GIMAP7 ENST00000313543 99.66 97.82 99.73 0.12 0.21 0.12 0.13 0.17 0.04
TCEB3CL2 ENST00000591973 98.23 98.83 99.73 0.09 0.16 0.12 0.11 0.14 0.04
IBA57-AS1 ENST00000366713 98.38 98.65 99.74 0.10 0.20 0.12 0.10 0.15 0.04
EBLN1 ENST00000422359 99.25 98.32 99.74 0.11 0.21 0.12 0.12 0.14 0.04
AL133373.1 ENST00000596306 99.61 97.63 99.75 0.12 0.22 0.12 0.13 0.19 0.04
MAGEA10 ENST00000370323 98.60 99.94 99.75 0.10 0.18 0.12 0.11 0.10 0.04
RNASE3 ENST00000304639 97.42 99.82 99.76 0.10 0.17 0.12 0.11 0.11 0.04
CALML5 ENST00000380332 98.53 98.56 99.76 0.10 0.20 0.12 0.11 0.15 0.04
FLJ45079 ENST00000374983 98.97 98.21 99.77 0.10 0.21 0.12 0.12 0.15 0.04
OR5L1 ENST00000333973 97.94 99.27 99.77 0.11 0.15 0.12 0.11 0.13 0.04
TAS2R1 ENST00000382492 99.48 97.80 99.78 0.11 0.21 0.12 0.13 0.18 0.04
IFNA5 ENST00000259555 97.84 99.48 99.78 0.11 0.16 0.12 0.11 0.13 0.04
KRTAP12-4 ENST00000391618 98.04 99.31 99.79 0.11 0.16 0.12 0.11 0.12 0.04
OR7G2 ENST00000305456 98.64 98.66 99.79 0.10 0.20 0.12 0.11 0.15 0.04
ADAM30 ENST00000369400 99.19 99.77 99.80 0.11 0.17 0.12 0.12 0.11 0.04
AC074389.6 ENST00000382528 97.95 99.54 99.80 0.11 0.16 0.12 0.11 0.13 0.04
POM121L12 ENST00000408890 98.02 99.46 99.81 0.11 0.16 0.12 0.11 0.13 0.04
LENG9 ENST00000333834 98.81 98.12 99.81 0.10 0.20 0.12 0.11 0.16 0.04

Cookies disclaimer

I agree Our site saves small pieces of text information (cookies) on your device in order to deliver better content and for statistical purposes. You can disable the usage of cookies by changing the settings of your browser. By browsing our website without changing the browser settings you grant us permission to store that information on your device.